{
    "data": [
        {
            "id": 2991820,
            "title": "American Integrity Releases 2025 Year-End Investor Presentation",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>American Integrity Insurance Group, Inc. ( <a data-ticker=\"AII\" href=\"https://www.tipranks.com/stocks/aii\">(AII)</a> ) has provided an update.</p>\n<p></p>\n<p></p><p><span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/aii\" target=\"_blank\" ;=\"\" rel=\"nofollow\">American Integrity Insurance Group, Inc.</a></span> has released a year-end 2025 investor presentation, which it plans to use in meetings with investors and analysts, including a scheduled presentation on March 2, 2026. The materials provide summary information on the insurer’s business, financial condition, results of operations and prospects, framed within its public SEC filings and recent Form 10-K for the year ended Dec. 31, 2025.</p>\n<p>The company stresses that the presentation is current only as of its date, may change without notice, and is being furnished rather than filed for securities law purposes, limiting associated liabilities. It also highlights the risks and uncertainties facing its Florida-focused property insurance operations, including catastrophe exposure, reinsurance availability, regulatory constraints and modeling limitations, while outlining the use of various non-GAAP metrics to assess operating performance.\n</p>\n<p>The most recent analyst rating on <a data-ticker=\"AII\" href=\"https://www.tipranks.com/stocks/aii\">(AII)</a> stock is a Buy with a $23.50 price target. To see the full list of analyst forecasts on American Integrity Insurance Group, Inc. stock, see the AII <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/aii/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on AII Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, AII is a Outperform.</p>\n<p>The score is driven primarily by very strong financial performance (sharp profitability improvement and a very low-debt balance sheet) and supportive earnings call guidance tied to reinsurance cost reductions and higher net revenue expectations. Valuation is exceptionally compelling based on the provided P/E. Offsetting factors are mixed technical momentum (negative MACD despite constructive moving averages) and business risk flags from the call, including Florida concentration and expected modest loss pressure.</p>\n<p>To see Spark’s full report on AII stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/aii/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about American Integrity Insurance Group, Inc.</u></b></p>\n<p>American Integrity Insurance Group, Inc. operates in the property and casualty insurance industry, conducting substantially all of its business in Florida. The company focuses on homeowners and related property coverage, relying on reinsurance markets, third-party distribution partners, and regulatory approvals in a catastrophe- and weather-exposed regional market.</p>\n<p><b>Average Trading Volume:</b> 142,848</p>\n<p><b>Technical Sentiment Signal:</b> Buy</p>\n<p><b>Current Market Cap:</b> $356.1M</p>\n<p></p>\n<p></p><p>Find detailed analytics on AII stock on <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/aii\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1150180799-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/american-integrity-releases-2025-year-end-investor-presentation",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 06:39:55",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991796,
            "title": "Aardvark Pauses ARD-101 Phase 3 HERO Trial Enrollment",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>The latest announcement is out from Aardvark Therapeutics, Inc. ( <a data-ticker=\"AARD\" href=\"https://www.tipranks.com/stocks/aard\">(AARD)</a> ).</p>\n<p></p>\n<p></p><p>On February 27, 2026, Aardvark Therapeutics said it had voluntarily paused enrollment and dosing in its Phase 3 HERO trial of ARD-101 for hyperphagia in Prader-Willi Syndrome, along with the related open-label extension study. The move followed reversible cardiac findings at above-target therapeutic doses in a separate healthy volunteer study, triggering a comprehensive data review and a delay to the previously expected third-quarter 2026 topline readout.</p>\n<p>Management emphasized that patient safety is the highest priority and that it remains committed to advancing ARD-101 while reassessing optimal dosing and working closely with regulators and clinical experts. The pause, while precautionary, introduces timing uncertainty for Aardvark’s lead program in a rare disease setting where ARD-101 holds Orphan Drug and Rare Pediatric Disease designations, potentially affecting expectations for the company’s near-term clinical and strategic milestones.</p>\n<p>The most recent analyst rating on <a data-ticker=\"AARD\" href=\"https://www.tipranks.com/stocks/aard\">(AARD)</a> stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Aardvark Therapeutics, Inc. stock, see the AARD <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/aard/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on AARD Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, AARD is a Neutral.</p>\n<p>The score is held back primarily by weak financial performance (pre-revenue, widening losses, and substantial cash burn implying funding risk). Offsetting factors include favorable technical momentum (price above major moving averages with positive MACD) and positive corporate pipeline milestones (Phase 3 HERO trial progress and updated program communications), while valuation remains constrained by ongoing losses and a negative P/E.</p>\n<p>To see Spark’s full report on AARD stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/aard/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Aardvark Therapeutics, Inc.</u></b></p>\n<p>Aardvark Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel small-molecule drugs to suppress hunger for Prader-Willi Syndrome and broader metabolic diseases. Its lead oral candidate, ARD-101, is in late-stage development for hyperphagia in PWS, while ARD-201, a fixed-dose combination of ARD-101 with a DPP-4 inhibitor, is being advanced through Phase 2 trials targeting limitations of existing GLP-1-based obesity treatments.</p>\n<p>The company’s approach focuses on hunger-specific neural pathways, distinct from appetite-driven reward mechanisms, and explores complementary use with anti-appetite therapies. ARD-101, a gut-restricted bitter taste receptor agonist that stimulates gut hormones such as GLP-1 and CCK, has received Orphan Drug and Rare Pediatric Disease designations from the FDA for PWS, underscoring its focus on rare metabolic indications and potential regulatory advantages.</p>\n<p><b>Average Trading Volume:</b> 188,388</p>\n<p><b>Technical Sentiment Signal:</b> Strong Buy</p>\n<p><b>Current Market Cap:</b> $276.1M</p>\n<p></p>\n<p></p><p>See more data about AARD stock on <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/aard\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1423187486-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/aardvark-pauses-ard-101-phase-3-hero-trial-enrollment",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 06:31:25",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991774,
            "title": "HASI Issues $600 Million Green Junior Subordinated Notes",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>HASI ( <a data-ticker=\"HASI\" href=\"https://www.tipranks.com/stocks/hasi\">(HASI)</a> ) just unveiled an announcement.</p>\n<p></p>\n<p></p><p>On February 27, 2026, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/hasi\" target=\"_blank\" ;=\"\" rel=\"nofollow\">HASI</a></span> issued $600 million of 7.125% Green Junior Subordinated Notes due 2056, guaranteed by several affiliated entities and structured as subordinated, unsecured debt ranking junior to senior obligations but senior to equity. The company plans to use the net proceeds to temporarily repay borrowings under its unsecured revolving credit facility and commercial paper programs or redeem a portion of its 8.00% Senior Notes due 2027, before directing an amount equal to the proceeds into new or existing eligible green projects, enhancing its funding flexibility and reinforcing its role as a provider of green capital for sustainable infrastructure.</p>\n<p>The notes carry a fixed 7.125% coupon until November 15, 2031, after which the rate resets every five years to the Five-year U.S. Treasury Rate plus 3.478%, with a floor of 7.125%, and permit interest deferral with compounding until maturity. HASI retained optional redemption features tied to specified dates, tax and rating agency events, and change of control, giving the company balance sheet and capital-structure optionality while offering investors a long-dated, higher-yield green security backed by guarantees from key operating subsidiaries.</p>\n<p>The most recent analyst rating on <a data-ticker=\"HASI\" href=\"https://www.tipranks.com/stocks/hasi\">(HASI)</a> stock is a Hold with a $41.00 price target. To see the full list of analyst forecasts on HASI stock, see the HASI <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/hasi/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on HASI Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, HASI is a Neutral.</p>\n<p>The score is held back primarily by volatile financial performance (sharp revenue swing, inconsistent cash flows) and elevated leverage. Offsetting this, technicals are favorable, the latest earnings call conveyed strong momentum with credible multi-year targets, and recent funding actions improve liquidity and flexibility; valuation is mixed with a high P/E despite an attractive dividend.</p>\n<p>To see Spark’s full report on HASI stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/hasi/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about HASI</u></b></p>\n<p>HA Sustainable Infrastructure Capital, Inc., known as HASI, operates as a specialty finance company focused on sustainable infrastructure. It provides capital to renewable energy and energy efficiency projects, positioning itself within the green finance market by funding eligible green projects that support decarbonization and climate-focused infrastructure assets.</p>\n<p><b>Average Trading Volume:</b> 1,018,783</p>\n<p><b>Technical Sentiment Signal:</b> Buy</p>\n<p><b>Current Market Cap:</b> $4.73B</p>\n<p></p>\n<p></p><p>Learn more about HASI stock on <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/hasi\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_387276601-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/hasi-issues-600-million-green-junior-subordinated-notes",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 06:20:58",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991764,
            "title": "Tennant Announces Retirement of Chief Transformation Officer Balinski",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Tennant Co ( <a data-ticker=\"TNC\" href=\"https://www.tipranks.com/stocks/tnc\">(TNC)</a> ) has provided an update.</p>\n<p></p>\n<p></p><p><span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/tnc\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Tennant Co</a></span>mpany said that Senior Vice President and Chief Transformation Officer Barb Balinski, 62, notified the company on February 26, 2026, of her plan to retire. Her retirement is scheduled for September 3, 2026, signaling an upcoming leadership transition in the executive team that may shape the company’s ongoing transformation efforts and strategic initiatives.</p>\n<p>The planned departure of a key transformation executive could influence how Tennant prioritizes operational change and innovation as it manages succession. Stakeholders will be watching how the company fills this role and maintains momentum on its transformation agenda following Balinski’s tenure.</p>\n<p>The most recent analyst rating on <a data-ticker=\"TNC\" href=\"https://www.tipranks.com/stocks/tnc\">(TNC)</a> stock is a Hold with a $64.00 price target. To see the full list of analyst forecasts on Tennant Co stock, see the TNC <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/tnc/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on TNC Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, TNC is a Neutral.</p>\n<p>The score is held back primarily by weakening 2025 financial performance (lower revenue, margins, and cash flow) and clearly bearish technicals (price far below major moving averages with weak momentum). Earnings call guidance points to improvement in 2026, but ERP-related disruption and elevated remediation spend keep near-term risk elevated, while valuation remains rich versus the current fundamentals.</p>\n<p>To see Spark’s full report on TNC stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/tnc/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Tennant Co</u></b></p>\n<p>Tennant Company is a manufacturer of cleaning and maintenance equipment, best known for its industrial and commercial floor-cleaning machines and related solutions. The company serves a broad range of institutional and industrial customers, focusing on improving cleaning efficiency and productivity in facilities worldwide.</p>\n<p><b>Average Trading Volume:</b> 145,775</p>\n<p><b>Technical Sentiment Signal:</b> Sell</p>\n<p><b>Current Market Cap:</b> $1.14B</p>\n<p></p>\n<p></p><p>For a thorough assessment of TNC stock, go to <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/tnc\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Industrials-2-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/tennant-announces-retirement-of-chief-transformation-officer-balinski",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 06:15:59",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991754,
            "title": "Avis Budget Nears Dismissal of Shareholder Derivative Lawsuits",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Avis Budget ( <a data-ticker=\"CAR\" href=\"https://www.tipranks.com/stocks/car\">(CAR)</a> ) just unveiled an update.</p>\n<p></p>\n<p></p><p><span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/car\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Avis Budget</a></span> Group, Inc., a major player in the global vehicle rental and mobility services market, was the nominal defendant in two shareholder derivative lawsuits filed in the U.S. District Court for the District of New Jersey in 2025. These suits targeted certain current and former officers and directors and stemmed from Avis’s February 2025 announcement that it was accelerating fleet rotation and recording a non-cash impairment for the fourth quarter of 2024.</p>\n<p>On October 22, 2025, the plaintiffs in these derivative actions moved to voluntarily dismiss their cases, and on November 24, 2025, the court ordered that Avis shareholders receive notice and an opportunity to intervene before any dismissal. If no shareholder moves to intervene by April 13, 2026, the Jones and Dua derivative actions will be dismissed without prejudice, easing immediate litigation pressure on Avis while preserving the possibility of similar claims being refiled in the future.</p>\n<p>The most recent analyst rating on <a data-ticker=\"CAR\" href=\"https://www.tipranks.com/stocks/car\">(CAR)</a> stock is a Buy with a $128.00 price target. To see the full list of analyst forecasts on Avis Budget stock, see the CAR <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/car/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on CAR Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, CAR is a Neutral.</p>\n<p>The score is held down primarily by weak financial performance (losses, sharp 2025 revenue decline, and a structurally weak balance sheet with negative equity) and bearish technicals (price below key moving averages with negative MACD). Partially offsetting factors include resilient operating cash flow, a neutral-but-action-oriented earnings call with liquidity actions (tax-credit monetization), and a modestly positive fleet refinancing event.</p>\n<p>To see Spark’s full report on CAR stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/car/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Avis Budget</u></b></p>\n<p>Avis Budget Group, Inc. operates in the global car and truck rental industry, providing vehicle rental and related mobility services to consumers and businesses under brands including Avis and Budget. The company focuses on serving both leisure and commercial travelers with short-term vehicle rentals and fleet management solutions across multiple markets.</p>\n<p><b>Average Trading Volume:</b> 651,970</p>\n<p><b>Technical Sentiment Signal:</b> Sell</p>\n<p><b>Current Market Cap:</b> $3.31B</p>\n<p></p>\n<p></p><p>For an in-depth examination of CAR stock, go to <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/car\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Overview page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Industrials-2-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/avis-budget-nears-dismissal-of-shareholder-derivative-lawsuits",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 06:10:37",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991746,
            "title": "Wyndham Issues $650 Million Senior Notes, Refinances Debt",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Wyndham Hotels &amp; Resorts ( <a data-ticker=\"WH\" href=\"https://www.tipranks.com/stocks/wh\">(WH)</a> ) has shared an update.</p>\n<p></p>\n<p></p><p>On February 27, 2026, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/wh\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Wyndham Hotels &amp; Resorts</a></span>, Inc. issued and sold $650 million of 5.625% senior unsecured notes due 2033, with interest payable semi-annually beginning September 1, 2026. The notes rank equally with the company’s existing senior debt, are guaranteed on a senior unsecured basis by certain domestic subsidiaries, and include standard covenants, change-of-control protections, and events-of-default provisions.</p>\n<p>Wyndham used the net proceeds from the offering to fully repay outstanding borrowings under its term loan A and revolving credit facility, fund related fees and expenses, and support general corporate purposes. The transaction refinances bank debt with longer-dated capital markets funding, potentially improving the company’s debt maturity profile while maintaining relationships with key lenders and initial purchasers that also participate in its credit facilities.</p>\n<p>The most recent analyst rating on <a data-ticker=\"WH\" href=\"https://www.tipranks.com/stocks/wh\">(WH)</a> stock is a Hold with a $89.00 price target. To see the full list of analyst forecasts on Wyndham Hotels &amp; Resorts stock, see the WH <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/wh/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on WH Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, WH is a Neutral.</p>\n<p>The score is primarily held back by elevated balance-sheet leverage and the sharp 2025 revenue/margin deterioration despite solid cash generation. Technicals are constructive with strong trend and momentum, while valuation looks rich at a 33.24 P/E with only a modest dividend yield. Earnings-call guidance supports modest 2026 growth but highlights continued RevPAR headwinds and franchisee-related fee uncertainty.</p>\n<p>To see Spark’s full report on WH stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/wh/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Wyndham Hotels &amp; Resorts</u></b></p>\n<p>Wyndham Hotels &amp; Resorts, Inc. is a lodging company that operates in the hotel and hospitality industry. The company focuses on franchising and managing hotel properties, offering accommodations across multiple brands and market segments to business and leisure travelers worldwide.</p>\n<p><b>Average Trading Volume:</b> 1,345,419</p>\n<p><b>Technical Sentiment Signal:</b> Strong Buy</p>\n<p><b>Current Market Cap:</b> $6.34B</p>\n<p></p>\n<p></p><p>See more data about WH stock on <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/wh\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Consumer-Cylical-6-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/wyndham-issues-650-million-senior-notes-refinances-debt",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 06:05:49",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991716,
            "title": "Mowi Chair Resigns; Leif Teksum Named Interim Board Leader",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Mowi ASA ( <a data-ticker=\"GB:0OAW\" href=\"https://www.tipranks.com/stocks/gb:0oaw\">(GB:0OAW)</a> ) just unveiled an update.</p>\n<p></p>\n<p></p><p>Mowi ASA announced that Ørjan Svanevik has resigned with immediate effect as Chair of the Board following the end of his employment with Seatankers Management, linked to major shareholder Geveran Trading. The nomination committee acknowledged his departure, confirmed the board still has a quorum, and appointed Vice Chair Leif Teksum as Interim Chair.</p>\n<p>Teksum, a board member since 2024, brings more than three decades of experience from DNB, including responsibility for the seafood sector, as well as board roles at companies such as Yara International and Nordic Trustee. His appointment provides continuity and sector-specific expertise at a sensitive governance juncture, helping to stabilize leadership and reassure investors under Norwegian securities disclosure rules.</p>\n<p>The most recent analyst rating on <a data-ticker=\"GB:0OAW\" href=\"https://www.tipranks.com/stocks/gb:0oaw\">(GB:0OAW)</a> stock is a Hold with a NOK220.00 price target. To see the full list of analyst forecasts on Mowi ASA stock, see the GB:0OAW <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/gb:0oaw/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>More about Mowi ASA</u></b></p>\n<p>Mowi ASA is a global seafood company and one of the world’s largest producers of farmed salmon, operating across the aquaculture value chain. The group focuses on sustainable salmon farming and related seafood products, supplying major retail and food service markets worldwide.</p>\n<p><b>Average Trading Volume:</b> 1,074,853</p>\n<p><b>Current Market Cap:</b> NOK118.1B</p>\n<p></p>\n<p></p><p>Find detailed analytics on 0OAW stock on <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/gb:0oaw\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Consumer-Defensive-5-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/mowi-chair-resigns-leif-teksum-named-interim-board-leader",
            "author": "TipRanks European Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 05:56:18",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991706,
            "title": "PrimeEnergy Amends Credit Facility, Reaffirms $115 Million Base",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Primeenergy ( <a data-ticker=\"PNRG\" href=\"https://www.tipranks.com/stocks/pnrg\">(PNRG)</a> ) has issued an announcement.</p>\n<p></p>\n<p></p><p>On February 24, 2026, PrimeEnergy Resources Corporation entered into a Fifth Amendment to its Fourth Amended and Restated Credit Agreement with Citibank and other lenders, reaffirming its borrowing base at $115 million. The amendment reduces interest margins on SOFR and base-rate loans by 50 basis points at each utilization level, updates commodity hedging covenants by raising certain utilization thresholds from 25% to 30%, adjusts lender schedules, and imposes customary post-closing mortgage and title delivery obligations, while leaving core facility terms such as commitments, collateral, covenants, and maturity unchanged.</p>\n<p>As of December 31, 2025, and February 27, 2026, PrimeEnergy had no outstanding borrowings, preserving full availability under the $115 million borrowing base. The changes are expected to lower the company’s cost of capital on future draws and provide slightly more flexibility around hedging requirements, supporting its liquidity position without altering the overall structure of its revolving credit facility.</p>\n<p>The most recent analyst rating on <a data-ticker=\"PNRG\" href=\"https://www.tipranks.com/stocks/pnrg\">(PNRG)</a> stock is a Buy with a $184.00 price target. To see the full list of analyst forecasts on Primeenergy stock, see the PNRG <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/pnrg/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on PNRG Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, PNRG is a Outperform.</p>\n<p>Primeenergy’s overall stock score is driven by its strong financial position and improving cash flow generation, despite challenges in revenue and profit margins. Technical analysis indicates short-term bullish momentum but warns of potential overbought conditions. Valuation is fair, though the lack of a dividend yield may deter some investors.</p>\n<p>To see Spark’s full report on PNRG stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/pnrg/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Primeenergy</u></b></p>\n<p>PrimeEnergy Resources Corporation operates in the energy sector and utilizes a senior secured revolving credit facility to support its operations. The company’s capital structure includes a borrowing base backed by oil and gas properties, with Citibank, N.A. serving as administrative agent under its primary credit agreement.</p>\n<p><b>Average Trading Volume:</b> 54,342</p>\n<p><b>Technical Sentiment Signal:</b> Strong Buy</p>\n<p><b>Current Market Cap:</b> $300.4M</p>\n<p></p>\n<p></p><p>Learn more about PNRG stock on <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/pnrg\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Energy-6-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/primeenergy-amends-credit-facility-reaffirms-115-million-base",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 05:51:04",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991699,
            "title": "Ocular Therapeutix Highlights Phase 3 AXPAXLI Trial Progress",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Ocular Therapeutix ( <a data-ticker=\"OCUL\" href=\"https://www.tipranks.com/stocks/ocul\">(OCUL)</a> ) has provided an announcement.</p>\n<p></p>\n<p></p><p>On February 27, 2026, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/ocul\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Ocular Therapeutix</a></span> announced that it would post investor presentation slides on its corporate website at 4:15 p.m. Eastern Time. The materials detail results from the SOL-1 Phase 3 superiority clinical trial of AXPAXLI (OTX-TKI) for the treatment of wet age-related macular degeneration, underscoring the company’s progress in advancing late-stage retinal disease therapies.</p>\n<p>The disclosure of Phase 3 data at the 49th Macula Society Annual Meeting highlights Ocular Therapeutix’s bid to strengthen its position in the competitive ophthalmology market. By sharing detailed trial outcomes with both clinicians and investors, the company is signaling a critical development milestone that could influence perceptions of its clinical pipeline and future commercial prospects.</p>\n<p>The most recent analyst rating on <a data-ticker=\"OCUL\" href=\"https://www.tipranks.com/stocks/ocul\">(OCUL)</a> stock is a Hold with a $8.00 price target. To see the full list of analyst forecasts on Ocular Therapeutix stock, see the OCUL <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/ocul/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on OCUL Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, OCUL is a Neutral.</p>\n<p>The score is held down primarily by weak financial performance (large and widening losses plus accelerating cash burn) and bearish technicals (below key moving averages with negative MACD). These are partially offset by a constructive earnings-call outlook centered on strong trial progress, upcoming SOL-1 data, and an extended cash runway, while valuation remains constrained by negative earnings and no dividend.</p>\n<p>To see Spark’s full report on OCUL stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/ocul/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Ocular Therapeutix</u></b></p>\n<p>Ocular Therapeutix, Inc. is a biopharmaceutical company focused on ophthalmology, developing therapies for eye diseases such as wet age-related macular degeneration. The company’s pipeline includes AXPAXLI (also known as OTX-TKI), designed as a treatment for retinal conditions that require long-acting, localized drug delivery.</p>\n<p><b>Average Trading Volume:</b> 5,749,145</p>\n<p><b>Technical Sentiment Signal:</b> Hold</p>\n<p><b>Current Market Cap:</b> $1.95B</p>\n<p></p>\n<p></p><p>For a thorough assessment of OCUL stock, go to <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/ocul\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_390599908-1-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/ocular-therapeutix-highlights-phase-3-axpaxli-trial-progress",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 05:46:11",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991681,
            "title": "Indaptus Shareholders Approve Major Charter and Capital Changes",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Indaptus Therapeutics ( <a data-ticker=\"INDP\" href=\"https://www.tipranks.com/stocks/indp\">(INDP)</a> ) has issued an update.</p>\n<p></p>\n<p></p><p>On February 26, 2026, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/indp\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Indaptus Therapeutics</a></span> held a special shareholders’ meeting at which investors elected Jerome Jabbour as a Class I director through the 2028 annual meeting and Matthew McMurdo as a Class III director through the 2027 meeting, with approximately 34.7% of outstanding common shares represented. Stockholders also approved multiple Nasdaq-related share issuance proposals, authorizing the issuance of common stock upon conversion of Series AA and Series AAA preferred shares, including shares issuable to the company’s co-chief executive officer and chairman.</p>\n<p>Investors further backed amendments to the charter to permit two reverse stock splits at ratios between 1-for-2 and 1-for-199, to be implemented at the board’s discretion, as well as an expansion of authorized common shares from 200 million to up to 1 billion. A charter amendment to allow shareholder action by written consent in lieu of a meeting was approved and became effective via a Certificate of Amendment filed in Delaware on February 27, 2026, giving the company greater flexibility in capital raising and corporate actions while potentially increasing future dilution risk for existing shareholders.</p>\n<p>The most recent analyst rating on <a data-ticker=\"INDP\" href=\"https://www.tipranks.com/stocks/indp\">(INDP)</a> stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Indaptus Therapeutics stock, see the INDP <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/indp/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on INDP Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, INDP is a Neutral.</p>\n<p>The score is held down primarily by weak financial performance (no revenue, sizable ongoing losses, and continued cash burn alongside a diminished equity/asset base). Technicals also remain bearish with the stock trading below all major moving averages and a negative MACD, despite oversold readings. Valuation provides limited support due to negative earnings and no dividend, while recent corporate events are mixed but secondary to the financial and trend risks.</p>\n<p>To see Spark’s full report on INDP stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/indp/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Indaptus Therapeutics</u></b></p>\n<p>Indaptus Therapeutics operates in the biopharmaceutical sector and is listed on Nasdaq, issuing common stock and multiple series of convertible preferred stock. The company’s governance structure includes a classified board, and its capital strategy relies on the flexibility to issue large volumes of equity and to adjust its share structure through mechanisms such as reverse stock splits.</p>\n<p><b>Average Trading Volume:</b> 715,452</p>\n<p><b>Technical Sentiment Signal:</b> Strong Sell</p>\n<p><b>Current Market Cap:</b> $4.51M</p>\n<p></p>\n<p></p><p>See more data about INDP stock on <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/indp\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_2157214825-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/indaptus-shareholders-approve-major-charter-and-capital-changes",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 05:40:12",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        }
    ]
}